Trupanion

Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the following segments: Subscription Business and Other Business. The Subscription Business segment is involved in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members. The company was founded by Darryl Rawlings in 2000 and is headquartered in Seattle, WA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Trupanion reports robust 2022 growth, eyes international expansion opportunities

Trupanion delivered strong financial performance in 2022, with significant revenue and income growth driven by pet acquisitions and retention strategies.
The company's focus on efficient capital deployment, expansion into new channels, and cash reserve position it well for future growth and profitability.
While facing challenges from pricing dynamics and international expansion, Trupanion's strategic initiatives present opportunities for sustained growth and market expansion.
With a positive outlook for 2023 and a solid foundation of customer data, Trupanion is poised to leverage its strengths and navigate challenges for continued success.

Trupanion reports robust Q1 earnings, eyes global expansion opportunities

Trupanion's Q1 2023 earnings call showcased strong financial performance, strategic focus on managing challenges related to inflation, and opportunities for global expansion and market growth. The company's effective pricing strategies and emphasis on long-term vision position it well for revenue growth and margin expansion in 2023.

Trupanion reports robust Q2 performance, eyes growth opportunities ahead

Trupanion's Q2 2023 performance reflects strong revenue growth, margin stabilization, and strategic cost management.
The company aims for disciplined growth, margin expansion, and sustained ARPU amidst challenges in revenue diversification and cost optimization.
Opportunities lie in continued rate increases, marketing efficiency improvements, and enhanced reporting for customer engagement and financial performance.

Trupanion reports robust Q3 earnings, eyes disciplined growth strategies

Trupanion's Q3 performance reflects strong revenue growth, margin expansion, and improved cash flow, underpinned by pricing power and customer loyalty.
While facing challenges in diversifying revenue streams and entering new markets, the company is well-positioned to leverage growth opportunities and maintain financial stability.
With a focus on disciplined growth, operational efficiency, and strategic investments, Trupanion aims to sustain positive momentum and capitalize on the growing pet insurance market.

Trupanion reports robust Q4 growth, focuses on margin expansion

Trupanion's Q4 performance reflects resilience amid industry challenges, with a strong focus on sustainable growth and financial discipline. The company's strategic initiatives to enhance member experience, prioritize margin expansion, and optimize capital deployment position it well for future opportunities.

Trupanion reports robust Q1 performance amidst market challenges and opportunities

Trupanion's Q1 2024 performance reflects strong revenue growth, margin expansion, and operational improvements driven by customer-centric strategies and efficient capital deployment.
While facing challenges such as inflation impacts and remediation efforts, the company's focus on margin expansion, market opportunities, and strategic initiatives positions it for future growth.
Investors can be optimistic about Trupanion's ability to navigate challenges, capitalize on growth opportunities, and drive profitability through effective pricing and operational efficiency.

Trupanion reports robust Q3 performance, eyes growth opportunities in Europe

Trupanion's Q3 performance reflects strong growth in subscription income and strategic initiatives to drive profitability and market expansion.
While challenges persist with inflation and cost management, the company's focus on efficiency and growth presents opportunities for sustained success.
Investors should note the positive operational improvements, the strategic market expansion into Europe, and the commitment to achieving sustainable margins.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Trupanion, Inc. engages in the provision of medical insurance for cats and dogs. It operates through the Subscription Business and Other Business. The Subscription Business segment is involved in the monthly subscriptions of pet medical insurance. The Others Business segment includes companies or organizations that choose to provide medical insurance for cats and dogs as a benefit to their employees or members. The company was founded by Darryl Rawlings in 2000 and is headquartered in Seattle, WA.

SEATTLE--(BUSINESS WIRE)--With pets holding a special place in our hearts as cherished family members, the need to ensure their well-being has never been more important. However, when faced with unexpected veterinary expenses, pet parents can find themselves grappling with tough decisions. Trupanion, medical insurance for cats and dogs, offers a quality solution, providing peace of mind that our pets can access the veterinary care necessary to preserve their health and well-being. Yet, in a mar.

Safeguarding Your Pet: Trupanion Dispels Common Pet Insurance Myths

Trupanion (TRUP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Trupanion (TRUP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

SEATTLE--(BUSINESS WIRE)--As the number one most frequently claimed condition among Trupanion pet parents, allergies in pets are a topic of increasing priority for pet parents. With over 20 years of pet health data, Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, has conducted a deep dive into its veterinary invoice data, revealing trends and insights as well as offering some practical tips for pet parents. Allergy Claims on the Rise Trupanion's anal.

truInsights into Pet Allergies: Trupanion Decodes Trends and Provides Tips for Pet Parents

SEATTLE--(BUSINESS WIRE)--Trupanion (Nasdaq: TRUP), the leading provider of pet medical insurance, is proud to announce the launch of truInsights, an initiative designed to deliver valuable health-related data and insights to pet parents. This initiative will provide a series of discussions covering topics relevant to everyday pet health, offering data-driven insights and practical advice to pet parents. Trupanion's years of pet health data and deep connections across the veterinary space enabl.

Trupanion Introduces truInsights: A Pet Health Data Initiative

Aflac

AMERISAFE

Employers Hlds

Unum

Lower claims frequency, moderate pricing and the adoption of technology are likely to boost the performance of Zacks Accident and Health Insurance industry players like AFL, UNM, EIG, AMSF and TRUP.

5 Stocks From the Prospering Accident & Health Insurance Industry

SEATTLE, April 19, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP), the leader in medical insurance for cats and dogs, announced today it will report financial results for its 2024 first quarter after the market closes on Thursday, May 2, 2024. The company will host a conference call that day beginning shortly after 1:30 p.m. PT / 4:30 p.m. ET.

Trupanion, Inc. Announces First Quarter 2024 Earnings Release and Conference Call

Freshpet

PetIQ

Two-thirds of American households own at least one pet, and large majorities of these pet owners view their companions as part of their families. Therefore, it's unsurprising that many households spend large amounts of money on their pets.

Unleash Your Portfolio: 3 Pet Stocks Poised to Fetch Big Returns

SEATTLE--(BUSINESS WIRE)--Trupanion, Inc. (Nasdaq: TRUP) received the following awards at the 18th annual Stevie Awards for Sales & Customer Service: A Silver Stevie® Award in the Contact Center of the Year, Financial Services category A Silver Stevie® Award in the Front-Line Customer Service Team of the Year, Financial Services category A Bronze Stevie® Award in the Inside and Telesales Team of the Year category The Stevie Awards for Sales & Customer Service are the world's top honors.

Trupanion Wins Silver Stevie® Award in 2024 Stevie Awards for Sales & Customer Service

SEATTLE, April 16, 2024 (GLOBE NEWSWIRE) -- Trupanion , Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, has published its 2023 annual shareholder letter, co-written by CEO and Chair, Darryl Rawlings, and President, Margi Tooth. The letter is now available on the Company's Investor Relations website  here .

Trupanion Publishes 2023 Annual Letter to Shareholders

SEATTLE--(BUSINESS WIRE)--Trupanion (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, was named a 2024 Stevie® Awards finalist in three Sales & Customer Service categories, solidifying Trupanion as a Gold, Silver, or Bronze Stevie Award winner in the following categories: Front-Line Customer Service Team of the Year, Financial Services Contact Center of the Year, Financial Services Inside and Telesales Team of the Year Trupanion strives to offer an unparalleled memb.

Trupanion Named 2024 Stevie® Awards Finalist for Three Sales & Customer Service Categories

BARK

Central Garden & Pet Company

In the flourishing pet care market, undervalued pet stocks are strategic choices for investors eyeing long-term portfolio expansion. These stocks latch onto the pet industry's powerful growth potential, marked by a 30% surge in global pet food sales from 2019 to 2023.

The Three Most Undervalued Pet Stocks to Buy in March 2024

NEW YORK , March 11, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Trupanion Inc. ("Trupanion" or the "Company") (NASDAQ: TRUP).  Such investors are advised to contact Robert S.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Trupanion Inc. - TRUP

SEATTLE, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP) announced today that Margi Tooth, President, will present at the Raymond James 2024 Institutional Investors Conference on Wednesday, March 6, 2024, at 9:50 a.m. ET and will participate in meetings with investors throughout the day.

Trupanion to Participate in the Raymond James 2024 Institutional Investors Conference

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Trupanion, Inc. (“Trupanion” or the “Company”) (NASDAQ: TRUP) investors concerning the Company's possible violations of federal securities laws. On February 15, 2024, Trupanion released its fourth quarter and full year 2023 preliminary financial results wherein the Company disclosed that it "expects to report two material weaknesses in internal controls" within its information technology contr.

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Trupanion, Inc. (TRUP) on Behalf of Investors

NEW YORK--(BUSINESS WIRE)---- $TRUP #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Trupanion, Inc. (“Trupanion” or “the Company”) (NASDAQ: TRUP). Investors who purchased Trupanion securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/TRUP. Investigation Details: On February 15, 2024, in a press release announcing its fourth quarter and full year 2023 financ.

Trupanion, Inc. (TRUP) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Trupanion, Inc. (“Trupanion” or the “Company”) (NASDAQ: TRUP) investors concerning the Company's possible violations of the federal securities laws. If you suffered a loss on your Trupanion investments or would like to inquire about potentially pursuing claims to recover your loss under the federal securities l.

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Trupanion, Inc. (TRUP) on Behalf of Investors

SEATTLE, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Building on its track record of consistently strong growth, Trupanion (Nasdaq: TRUP), a leading provider of medical insurance for cats and dogs, today announced that it has enrolled its one millionth subscription pet across its portfolio of subscription brands in North America and Continental Europe.

Trupanion, Inc. Surpasses 1 Millionth Subscription Pet Milestone

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Trupanion, Inc. (“Trupanion” or the “Company”) (NASDAQ: TRUP) on behalf of investors concerning the Company's possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. On February 15, 2024, Trupanion released its fourth quarter and full year 2023 preliminary financial results wherein the Company disclosed that that it "expects to report two.

The Law Offices of Frank R. Cruz Announces Investigation of Trupanion, Inc. (TRUP) on Behalf of Investors

SEATTLE, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Trupanion, Inc. (Nasdaq: TRUP) announced today that Margi Tooth, President, and Fawwad Qureshi, Chief Financial Officer, will present at the Bank of America 2024 Financial Services Conference on Wednesday, February 21, 2024, at 2:30 p.m. ET and will participate in meetings with investors throughout the day.

Trupanion to Participate in the Bank of America 2024 Financial Services Conference

Biomea Fusion Inc

Hive Blockchain Technologies Ltd

Financial advisors rarely if ever recommend speculative stocks because they don't want to get sued. Let's be real here.

3 Speculative Stocks That Could Make Your February Unforgettable

Trupanion announced better-than-expected preliminary Q4 2023 results. But the pet insurance company also told investors it expects to report two "material weaknesses" in internal controls when it files its annual report.

Why Trupanion Stock Plummeted Today

OAKLAND, Calif.--(BUSINESS WIRE)---- $TRUP #TRUP--Shares of Trupanion, Inc. (“Trupanion”) dropped over 35% on February 16, 2024, after the company revealed that it “expects to report two material weaknesses in internal controls.” Gibbs Law Group is investigating a potential Trupanion, Inc. Securities Class Action Lawsuit on behalf of shareholders who lost money in Trupanion, Inc. (NASDAQ: TRUP). What Should Trupanion Inc. Investors Do? If you invested in Trupanion, Inc., visit our website by clicking here, or.

Lost Money in Trupanion, Inc.? Gibbs Law Group Investigates Potential Securities Law Violations

Trupanion, Inc. (TRUP) Q4 2023 Earnings Call Transcript

Subscription revenue growth accelerated while margins continued to expand sequentially Subscription revenue growth accelerated while margins continued to expand sequentially

Trupanion Reports Fourth Quarter & Full Year 2023 Results

SEATTLE--(BUSINESS WIRE)--Trupanion webinar addresses canine respiratory illness.

News for Trupanion Stock (TRUP)